RAPS is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization.

Stay informed on the latest healthcare regulatory news through RAPS’ online magazine, Regulatory Focus and its companion daily e-newsletter RF Today, or by following RAPS on social media, including TwitterLinkedIn and Facebook.

Reporters, bloggers and other members of the media interested in covering RAPS events or programs should contact Zachary Brousseau, senior manager of communications, at zbrousseau@raps.org or by calling +301 770 2920 ext. 245.

Press Releases

108 more professionals earn RAC

Posted 09 December 2021 | By Zachary Brousseau 

RAPS today announced that 108 professionals passed the Regulatory Affairs Certification (RAC) exams in the summer exam window, which occurred in July and August 2021. Passing the exam confers ...

RAPS releases updated Regulatory Competency Framework

Posted 30 November 2021 | By Zachary Brousseau 

RAPS today announced the release of its updated Regulatory Competency Framework, describing the essential elements of what is required of regulatory professionals at four key career and profes...

RAPS Convergence 2021 brings regulatory community together virtually to hear from regulators, learn from each other and celebrate the profession

Posted 15 September 2021 | By Zachary Brousseau 

RAPS today wrapped up its annual RAPS Convergence, the world’s largest conference dedicated to healthcare product regulation and regulatory issues. The event drew more than 1,500 participants ...

Global regulatory workforce nearly 100K, says new report from RAPS, Elemed

Posted 15 September 2021 | By Zachary Brousseau 

Nearly 100,000 professionals around the world currently work in the field of regulatory affairs for healthcare products, such as pharmaceuticals, medical devices, and biotechnology products, i...

RAPS honors 7 distinguished individuals and an advocacy group for contributions to the regulatory profession and patient health

Posted 09 September 2021 | By Zachary Brousseau 

RAPS has recognized seven distinguished professionals and one patient advocacy organization with awards for their work to support the regulatory profession and advance public health. RAPS’ Fou...

RAPS in the News

Goldman Predicts ‘At Least One’ Vaccine Approval Before The End Of 2020, Raises GDP Estimate | Forbes

Posted 12 August 2020 | By Sergei Klebnikov

...of 42 companies that have vaccines currently under development, according to the Regulatory Affairs Professionals Society...

Arcturus Therapeutics Has Begun A Phase 1/2 Study On Its Covid-19 Vaccine Candidate | Forbes

Posted 11 August 2020 | By Jim Collins

...in the race to a Covid-19 vaccine includes no fewer than 42 entities named by the Regulatory Affairs Professionals Society...


Posted 28 July 2020 | By Alex Keown

...the nation’s food supplies. First reported by Regulatory Focus, the publication of the Regulatory Affairs Professionals Society (RAPS)...

Experts urge transparency and advisory committee review for COVID-19 vaccines | Healthcare Purchasing News

Posted 15 July 2020

...advisory committee review will be key to the effective rollout of a vaccine to prevent coronavirus disease (COVID-19), reports the Regulatory Affairs Professionals Society. 

  • 1
  • 2